Novel molecular marker may improve prostate cancer treatment

Working model depicting the inferred functional interaction between TMPRSS2-ERG and the hormone-activated glucocorticoid receptor in prostate cancer. Credit: EMBO Molecular…

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *